BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CANG
Cango Inc.
There isn't enough reported data to score CANG yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CANG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
CANG's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CANG PE Valuation
CANG has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CANG on the outlook, with more favorable revenue expectations.
CANG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CANG's losses to shrink, with revenue declining.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
CANG has the stronger earnings trend. Trailing diluted EPS is down 52% for BABA versus CANG down 49%.
CANG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $0.97 | +$1.09 |
| Q4 2023 | -$0.12 | +$2.93 |
| Q4 2022 | -$3.05 | -$3.02 |
| Q3 2022 | -$1.17 | -133% |
| Q2 2022 | -$1.89 | -121% |
| Q1 2022 | $0.30 | -96% |
| Q4 2021 | -$0.03 | -100% |
| Q3 2021 | $3.54 | -26% |
CANG has returned to profit: it earned $0.97 per share over the past year, after losing money the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
CANG has the stronger quarterly revenue trend. Revenue is up 8.3% for BABA versus up 453% for CANG.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
CANG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $404.1M | +235% |
| Q4 2024 | $120.7M | -53% |
| Q4 2023 | $255.4M | +249% |
| Q4 2022 | $73.1M | -54% |
| Q3 2022 | $62.5M | -48% |
| Q2 2022 | $43.4M | -69% |
| Q1 2022 | $118.2M | -30% |
| Q4 2021 | $157.7M | -4.3% |
CANG's revenue has grown year over year for four quarters in a row: $404M last quarter, up 453% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -58% | -14 points |
| Q2 2025 | -72% | -26 points |
| Q4 2024 | 22% | +145 points |
| Q4 2023 | -4.3% | +20 points |
| Q4 2022 | -43% | -29 points |
| Q3 2022 | -46% | -41 points |
| Q2 2022 | -122% | -124 points |
| Q1 2022 | -24% | -38 points |
CANG's operating margin was −58% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2016.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
CANG has the stronger cash trend. Its trailing FCF is up 365% versus its history, compared with BABA at down 158%.
CANG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$46.6M | -130% |
| Q4 2023 | $153.7M | +$153.7M |
| Q4 2022 | $0 | $0 |
| Q3 2022 | $0 | $0 |
| Q2 2022 | $0 | $0 |
| Q1 2022 | $0 | $0 |
| Q4 2021 | $0 | $0 |
| Q3 2021 | $0 | $0 |
CANG usually generates cash, though not every quarter: the latest was −$47M, but it generated $107M over the past year.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CANG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.5% | -4.4M shares |
| 1 year | -23% | -12.4M shares |
| 3 years | -30% | -17.9M shares |
| 5 years | -17% | -8.4M shares |
| Available history | -17% | -8.4M shares |
CANG has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $13.6M |
| Q4 2023 | $37M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
CANG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -4.4x | Net Cash |
| Q4 2021 | 3.1x | Elevated |
| Q3 2021 | 4.0x | Elevated |
| Q2 2021 | 2.3x | Moderate |
| Q1 2021 | 1.5x | Healthy |
| Q4 2020 | 3.4x | Elevated |
| Q3 2020 | 4.0x | High |
| Q2 2020 | 0.8x | Very low |
CANG has more cash than debt.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CANG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.8 | Neutral |
| Stochastic | 9.7 | Oversold |
CANG's weekly RSI is 40 (neutral) and its Stochastic is 10 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CANG PE vs Consumer Cyclical Sector
| Metric | CANG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CANG has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CANG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.09 | 24% below |
| 20 week MA | $2.03 | 22% below |
| 50 week MA | $5.48 | 71% below |
| 100 week MA | $13.7 | 88% below |
| 200 week MA | $10.7 | 85% below |
CANG is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over CANG on returns for 2026, with the stronger performance.
CANG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.0 | $36.3 | -16% |
| 2021 | $36.3 | $16.1 | -56% |
| 2022 | $16.1 | $6.70 | -58% |
| 2023 | $6.70 | $5.10 | -24% |
| 2024 | $5.10 | $24.6 | +382% |
| 2025 | $24.6 | $13.9 | -43% |
| 2026 YTD | $13.9 | $1.59 | -89% |
CANG's yearly returns have swung widely, from +382% in 2024 to −58% in 2022. It's down 89% so far in 2026.